Cadarette S, Rementeria MA, Espinosa EG, Stewart F, Brisibe T, Devani D, Kistler K, Oladapo T, Rangi ND, Wissinger E. Quality of life (QOL) instruments used in clinicaltrials.gov-indexed trials of gene-modified cell therapy (GMCT) in patients with multiple myeloma (MM). Poster presented at the ISPOR Europe 2023; November 12, 2023. Copenhagen, Denmark. [abstract] Value Health. 2023 Dec; 26(12 Supplement):S495. doi: 10.1016/j.jval.2023.09.2676
Wissinger E, Koufopoulou M, Fusco N, Stewart F, Oladapo T, Depalma S, Devani D, Rangi ND. Surrogate endpoints in oncology: a review of recent health technology appraisals in the United Kingdom. Poster presented at the ISPOR 2023; May 7, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 Suppl):S265-6. doi: 10.1016/j.jval.2023.03.1470
Koufopoulou M, Wissinger E, Oladapo T, Stewart F, Depalma S, Devani D, Rangi ND, Fusco N. The use of real-world data in decision making for oncology: a review of recent health technology appraisals in the United Kingdom. Poster presented at the ISPOR 2023; May 7, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 Suppl):S262. doi: 10.1016/j.jval.2023.03.1453
Stirnadel-Farrant H, Mahajan A, Dhillon N, Patel N, Pokras S. Current treatment efficacy for metastatic soft tissue sarcoma: a targeted literature review. Poster presented at the 2020 ASCO Annual Meeting I; May 25, 2020. Chicago, IL. [abstract] J Clin Oncol. 2020 Jun; 38(15_Suppl). doi: 10.1200/JCO.2020.38.15_suppl.e23577